SLC5A2 and heart failure: Several clinical studies investigating the efficacy of SGLT2 inhibitors1–6,11,12 have reported consistent positive effects of SGLT2 inhibitors, such as lowering serum glucose, preventing hospitalisation for heart failure, and renal protection.